Supplementary Material from Molecular and Immunologic Signatures Are Related to Clinical Benefit from Treatment with Vocimagene Amiretrorepvec (toca 511) and 5-Fluorocytosine (toca FC) in Patients with Glioma
openalex(2023)
关键词
Tumor Microenvironment
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要